Category: Health Care Costs

Study strengthens support for price transparency

Health plans have been calling on providers to improve transparency in pricing, and a new study in the Journal of the American Medical Association backs up those calls. Continue reading

Posted in: Health Care Costs, Issue Alert

JAMA: Hospital ownership and higher prices

A new study published today in the Journal of the American Medical Association highlights something we’ve been concerned about for years – that provider consolidation increases prices for services and costs for patients. Continue reading

Posted in: Health Care Costs, Issue Alert

Politico Pro: Backlash builds over soaring drug prices

With a wave of new treatments carrying six-figure price tags in the pipeline, pressure is building on drugmakers to lower their prices, according to a new Politico Pro article. Continue reading

Posted in: Health Care Costs, Issue Alert

Chart of the day: Price increases are most important driver of spending growth

As you can see in the chart below, spending on cancer drugs far outpaces the increase in the number of units being used. This means increases in price for cancer drugs are largely driving increases in spending. Continue reading

Posted in: Health Care Costs

AHIP statement on Harvoni

America’s Health Insurance Plans (AHIP) Spokesman Brendan Buck released the following statement today after Gilead Sciences announced its newly approved hepatitis C drug Harvoni will be priced at $94,500 for a course of treatment. Continue reading

Posted in: Cost Alert, Health Care Costs

Any willing provider laws grab headlines in South Dakota

Any willing provider (AWP) laws – which allow any doctor or hospital to enter into a plan network – are making headlines thanks to a proposal on the ballot in South Dakota that would institute an AWP law and could prompt other states to consider similar policies. Continue reading

Posted in: Health Care Costs, Issue Alert

Chart of the day: Price matters

A new Morning Consult poll should serve as yet another a wake-up call for drugmakers, pushing them to be part of the solution to unaffordable and unsustainable prescription drugs. Continue reading

Posted in: Health Care Costs, Issue Alert

7 things we learned at the Health Affairs briefing on specialty drugs

Specialty drugs took center stage at today’s Health Affairs event, which introduced research from the October issue titled “Specialty Pharmaceutical Spending and Policy.” Below are some highlights. Continue reading

Posted in: Health Care Costs

NEWSFLASH: Many High-Price Drugs Are Covered the Same as a Hospital Visit

Why do you cover drugs so differently than a trip to the hospital? That’s the cry often heard from drugmakers as they try to defend the astronomical prices for some of their products. But it knowingly misleads from the fact that these high-priced drugs are often administered and paid for through health plan medical benefits. Continue reading

Posted in: Health Care Costs, Issue Alert

Moment of Truth: Gilead Comes to a Pricing Decision Point

The eyes of the health care world – and prime time TV audiences – are focused this week on the high prices of many pharmaceutical drugs. And one looming decision will tell us whether the tide has turned in favor of sustainable pricing – or whether drugmakers still have their heads in the sand. Continue reading

Posted in: Cost Alert, Health Care Costs